Haemonetics Corporation's Acquisition Wins LifeSciences British Columbia Medical Device Company of the Year Award

Published: Apr 20, 2010

BRAINTREE, Mass., April 20 /PRNewswire-FirstCall/ -- Haemonetics Corporation (NYSE:HAE - News) announced today that Neoteric Technology Ltd, a corporate acquisition in 2009, currently doing business as Haemonetics Canada, LTD, was named the LifeSciences British Columbia Medical Device Company of the Year.

Haemonetics was recognized for providing patient safety and tracking solutions to acute care hospitals over the last 13 years. The solutions ensure that critical treatments are given to the right patient at the right time in the right dose, and are now installed in more than 180 hospitals in 5 countries.

In particular, the award recognized the revolutionary BloodTrack® blood transfusion and inventory management system. The BloodTrack suite is comprised of eight solutions, including the HemoSafe automated blood dispensing system and BloodTrack Tx, a bedside point-of-care system that utilizes the latest mobile bar code technology to ensure that the right blood is transfused to the right patient. Each BloodTrack solution is integrated into BloodTrack Manager, a central dashboard that provides hospitals with a comprehensive, real-time view of their entire transfusion service.

Using BloodTrack, hospitals are able to reduce the time to make blood available to patients 'just in time' instead of 'just in case' while improving the efficiency of the hospital transfusion process. As published in the journal Transfusion (2008, vol. 48), the time to access blood in the operating room was reduced from 24 minutes to 59 seconds, and the time required for blood bank and clinical staff to manage blood preparation and delivery was reduced from 117 minutes to 34 minutes a day. At the same time, the number of blood units issued from the hospital blood bank was reduced by 52%.

The award was presented at a gala ceremony in front of an audience of approximately 600 medical device, bioproducts, and greater life sciences community leaders at the Vancouver Convention Centre on Wednesday, April 14th, 2010.

"The theme of our 2010 LifeSciences BC Awards is 'Bridges to the Future', and each of these recipients has brought us new knowledge, leadership, innovation and technologies to create a better future for humankind," commented Karimah Es Sabar, President of LifeSciences British Columbia. "We thank and applaud each of them for their tremendous efforts, insight, and commitment to a better future through great science and the commercialization and adoption of that science achieved right here in British Columbia."

Regarding the award, Geof Auchinleck, Site Director of Haemonetics Canada, LTD said, "We are delighted to receive this award following the years of hard work and dedication by our team to improving the lives of patients and hospital caregivers, particularly in transfusion management."

About LifeSciences British Columbia

LifeSciences British Columbia supports and represents the biopharmaceutical, medical device, bioproducts, bioenergy and greater life sciences community of British Columbia through leadership, advocacy and promotion of our world-class science and industry. Via active facilitation of partnering and investment into the life sciences sector, British Columbia is fast becoming a global life sciences leader. LifeSciences British Columbia is a not-for-profit, non-government, industry-funded association.

The LifeSciences British Columbia Awards are presented by Ernst & Young; Farris, Vaughan, Wills & Murphy, LLP; Genome British Columbia; and Rx&D (Canada's Research-Based Pharmaceutical Companies). Media sponsor: Business in Vancouver Magazines.

About Haemonetics Corporation

Haemonetics Corporation is a global healthcare company dedicated to providing innovative blood management solutions for our customers.

In the hospital, our BloodTrack® suite of solutions is a comprehensive blood tracking, dispensing and transfusion management system that provides the hospital Blood Transfusion Service with the ability to monitor and automatically allocate blood outside of the Blood Bank, then ensure that the blood is transfused to the correct patient at the point-of-care. The system also maintains a complete audit of all activities enabling a hospital to comply with applicable regulations.

Together, Haemonetics' devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world.

To learn more about Haemonetics, the BloodTrack system, and other Haemonetics' blood management solutions, visit our web site at www.haemonetics.com.

CONTACT: Bryanne Salmon Tel. (781) 356-9613

Back to news